Myris Therapeutics
  • HOME
  • COMPANY
    • ABOUT
    • OUR TEAM
    • SCIENTIFIC PUBLICATIONS
  • NEWS
  • CONTACT
Select Page

Company

Recent Posts

  • Myris Therapeutics is Developing Ultra-High DAR ADCs to Enable Novel Precision Medicine Treatments for Cancer
  • BioHybrid Solutions Holdings, Inc. Announces Expansion of its Drug Development Leadership  
  • BioHybrid Solutions Holdings, Inc. Appoints Mark Murcko as Board Member
  • BioHybrid Solutions™ announces the formation of its Holdings Corporation and Subsidiaries
  • BioHybrid Solutions™ Announces Jean Pineault as President and Chief Executive Officer

Recent Comments

    Archives

    • February 2025
    • June 2023
    • September 2022
    • May 2022
    • January 2022
    • December 2019
    • November 2019
    • April 2017
    • November 2016
    • October 2016
    Copyright © Myris Therapeutics

    Powered by
    ►
    Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
    None
    ►
    Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
    None
    ►
    Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
    None
    ►
    Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
    None
    ►
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
    None
    Powered by